Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "AREA[SponsorSearch](Janssen Research & Development)"
Count: 959
Selected: 0
| NCT ID | Title |
|---|
| NCT02342249 | Study of Acute Uncomplicated Seasonal Influenza A in Adult Subjects | ||
| NCT00207688 | A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients | ||
| NCT03795402 | Analysis of Non-Invasively Collected Microneedle Device Samples From Mild Plaque Psoriasis for Use in Transcriptomics Profiling | ||
| NCT01362699 | Effect of JNJ 31001074 on Urge to Drink in Alcohol-Dependent Adults | ||
| NCT02293395 | A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome | ||
| NCT05572515 | A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma | ||
| NCT05564052 | A Study of Ibrutinib With Rituximab in Relapsed/Refractory Mantle Cell Lymphoma | ||
| NCT05552222 | A Study to Compare Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) in Participants With Newly Diagnosed Multiple Myeloma | ||
| NCT05550532 | A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy | ||
| NCT05541315 | A Single Ascending Dose Study of JNJ-88260237 in Healthy Participants | ||
| NCT05528510 | A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis | ||
| NCT05522517 | A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appendix 4 | ||
| NCT05521087 | A Study of JNJ-75276617 in Combination With Conventional Chemotherapy for Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias | ||
| NCT05518149 | A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD) | ||
| NCT05503550 | Pre-Approval Access Single Patient Request for Talquetamab in Relapsed or Refractory Multiple Myeloma | ||
| NCT05498428 | A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer | ||
| NCT05488314 | A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic Non-small Cell Lung Cancer | ||
| NCT05463939 | Teclistamab Expanded Access Treatment Protocol for Relapsed or Refractory Multiple Myeloma Patients | ||
| NCT05461209 | A Study of Comparing Talquetamab to Belantamab Mafodotin in Participants With Relapsed/Refractory Multiple Myeloma | ||
| NCT05455684 | A Study of Aticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy | ||
| NCT05455320 | A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma | ||
| NCT05453903 | A Study of JNJ-75276617 in Combination With Acute Myeloid Leukemia (AML) Directed Therapies | ||
| NCT05444530 | A Study of VAC85135, a Neoantigen Vaccine Regimen, Concurrently Administered With Ipilimumab for the Treatment of Myeloproliferative Neoplasms | ||
| NCT05441501 | A Study of JNJ-80038114 in Participants With Advanced Stage Prostate Cancer | ||
| NCT05438043 | A Study of Daratumumab | ||
| NCT05424822 | A Study of JNJ-80948543, a T Cell Redirecting Antibody, in Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL) | ||
| NCT05423106 | A Single and Multiple Ascending Dose Study of JNJ-64457744 | ||
| NCT05407818 | A Study of JNJ-63733657 in Healthy Chinese Participants | ||
| NCT05401214 | Pre-approval Access Single Patient Request for Niraparib / Abiraterone Acetate Combination (Nira/AA Combination) | ||
| NCT05388669 | A Study of Lazertinib and Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer | ||
| NCT05387759 | A Thorough QT Study of Aticaprant (JNJ-67953964) in Healthy Adult Participants | ||
| NCT05379634 | A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies | ||
| NCT05379595 | A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer | ||
| NCT05378906 | A Study of Darunavir in the Presence of Cobicistat When Administered as a Fixed Dose Combination Compared to the Co-administration of the Separate Available Formulations of Darunavir and Cobicistat Under Fed Conditions in Healthy Participants | ||
| NCT05364554 | A Long-term Extension Study of JNJ-77242113 in Participants With Moderate-to-Severe Plaque Psoriasis | ||
| NCT05357755 | A Study of JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque Psoriasis | ||
| NCT05338775 | A Study of Talquetamab and Teclistamab Each in Combination With a Programmed Cell Death Receptor-1 (PD-1) Inhibitor for the Treatment of Participants With Relapsed or Refractory Multiple Myeloma | ||
| NCT05327114 | Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) | ||
| NCT05316155 | Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer | ||
| NCT05307692 | A Study of Seltorexant in Participants With Probable Alzheimer's Disease | ||
| NCT05295927 | A Study of EPI-7386 in Combination With Abiraterone Acetate Plus Prednisone, or Apalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) | ||
| NCT05275023 | An Efficacy and Safety Study of a Combination of JNJ-73763989, Nucleos(t)Ide Analogs (NA), and a Programmed Cell Death Protein Receptor-1 (PD-1) Inhibitor in Chronic Hepatitis B Participants | ||
| NCT05272150 | Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp Psoriasis | ||
| NCT05268497 | A Study to Assess Feasibility of Using Clinician-directed and Digital Application Supported Cognitive Behavior Therapy (CBT) in Conjunction With Esketamine in Participants With Treatment-resistant Depression | ||
| NCT05265273 | A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis | ||
| NCT05252533 | A Study of Ustekinumab in Pediatric Participants (U-POPS) With Juvenile Psoriatic Arthritis or Psoriasis | ||
| NCT05252520 | A Study of JNJ-77474462 (Bermekimab) in Healthy Chinese Participants | ||
| NCT05250973 | A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) Amyloidosis | ||
| NCT05242484 | A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis | ||
| NCT05242471 | A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease |
